Photo by museumsvictoria from unsplash
Drug makers are targeting flu virus vulnerabilities to develop antivirals that not only stop infections in their tracks, but also temper emergence of drug resistance.Drug makers are targeting flu virus… Click to show full abstract
Drug makers are targeting flu virus vulnerabilities to develop antivirals that not only stop infections in their tracks, but also temper emergence of drug resistance.Drug makers are targeting flu virus vulnerabilities to develop antivirals that not only stop infections in their tracks, but also temper emergence of drug resistance.
Keywords:
chase anti;
makers chase;
drug;
drug makers;
anti flu
Journal Title: Nature Biotechnology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Nature Biotechnology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!